When Should Heart Failure Treatment Be Down-Titrated or Stopped?
CLINICAL CONTEXT
When Should Heart Failure Treatment Be Down-Titrated or Stopped?
This expert-led session explores a practical question in heart failure with reduced ejection fraction. It is designed to support a structured clinical discussion around evidence-based care, patient status and appropriate follow-up.
The video should be interpreted alongside current guidelines, local protocols and the individual circumstances of each patient.
SYNOPSIS
“
A practical reflection on when and how heart failure treatment may need to be reviewed, reduced or interrupted.
FEATURED SPEAKER
Prof. Alexander Mebazaa
Department of Anesthesiology and Critical Care, University Hospital Saint Louis & Lariboisière Université, Paris, France
IN THIS VIDEO
Key clinical perspectives
- Clarifying why a change is considered
- Reviewing the wider clinical picture
- Supporting individualised care planning
This video is intended for healthcare professionals and supports clinical education. It does not replace individual clinical judgement or local guidance.
Previous Post
Managing HFrEF in Patients With Low Blood Pressure
Next Post
Early MRA Initiation in HFrEF: Why Timing Matters